APC mutations are infrequent but present in human lung cancer

Cancer Letters

Volumn 207, Issue 2, 2004, Pages 197-203

  Ohgaki, Hiroko ^a   Kros, Johan M ^b   Okamoto, Yoshikazu ^a   Gaspert, Ariana ^c   Huang, Hervé ^a   Kurrer, Michael O ^c  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

catenin immunohistochemistry; Adenocarcinoma; APC mutation; Lung squamous cell carcinoma; Small cell lung carcinoma

Indexed keywords

APC PROTEIN; BETA CATENIN;

ARTICLE; CANCER SCREENING; CODON; COLON POLYPOSIS; CONTROLLED STUDY; DNA SEQUENCE; EXON; GENE CLUSTER; GENE DELETION; GENE DISRUPTION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA; STAINING;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CYTOSKELETAL PROTEINS; GENES, APC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 1842557423     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2003.10.020     Document Type: Article

References (39)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol. 2:2001;533-543.
2. Wistuba I.I., Lam S., Behrens C., Virmani A.K., Fong K.M., LeRiche J., et al. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl Cancer Inst. 89:1997;1366-1373.
3. Kawanishi M., Kohno T., Otsuka T., Adachi J., Sone S., Noguchi M., et al. Allelotype and replication error phenotype of small cell lung carcinoma. Carcinogenesis. 18:1997;2057-2062.
4. Sekido Y., Fong K.M., Minna J.D. Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta. 1378:1998;F21-F59.
5. Wistuba I.I., Gazdar A.F., Minna J.D. Molecular genetics of small cell lung carcinoma. Semin. Oncol. 28:2001;3-13.
6. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25:2000;315-319.
7. Croce C.M., Sozzi G., Huebner K. Role of FHIT in human cancer. J. Clin. Oncol. 17:1999;1618-1624.
8. Kohno T., Yokota J. How many tumor suppressor genes are involved in human lung carcinogenesis? Carcinogenesis. 20:1999;1403-1410.
9. Fong K.M., Zimmerman P.V., Smith P.J. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer. Cancer Res. 55:1995;220-223.
10. Cooper C.A., Bubb V.J., Smithson N., Carter R.L., Gledhill S., Lamb D., et al. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation. J. Pathol. 180:1996;33-37.
11. D'Amico D., Carbone D.P., Johnson B.E., Meltzer S.J., Minna J.D. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res. 52:1992;1996-1999.
12. Hosoe S., Ueno K., Shigedo Y., Tachibana I., Osaki T., Kumagai T., et al. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res. 54:1994;1787-1790.
13. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell. 66:1991;589-600.
14. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., et al. Identification of FAP locus genes from chromosome 5q21. Science. 253:1991;661-665.
15. Akiyama T. Wnt/β-catenin signaling. Cytokine Growth Factor Rev. 11:2000;273-282.
16. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Ando H., et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 52:1992;6696-6698.
17. Furuuchi K., Tada M., Yamada H., Kataoka A., Furuuchi N., Hamada J., et al. Somatic mutations of the APC gene in primary breast cancers. Am. J. Pathol. 156:2000;1997-2005.
18. Sunaga N., Kohno T., Kolligs F.T., Fearon E.R., Saito R., Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (β-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer. 30:2001;316-321.
19. Shigemitsu K., Sekido Y., Usami N., Mori S., Sato M., Horio Y., et al. Genetic alteration of the β-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion. Oncogene. 20:2001;4249-4257.
20. Tsujiuchi T., Tsutsumi M., Sasaki Y., Murata N., Konishi Y. Mutations of adenomatous polyposis coli and β-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats. Cancer Res. 60:2000;6611-6616.
21. Travis W.D., Colby T.V., Corrin B., Shimosato S., Brambilla E. Histological Typing of Lung and Pleural Tumours. third ed. 1999;Springer, Berlin.
22. Huang H., Fujii H., Sankila A., Mahler-Araujo B.M., Matsuda M., Cathomas G., Ohgaki H. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 156:1999;1795-1801.
23. Tsuda M., Kamimura K., Nakato H., Archer M., Staatz W., Fox B., et al. The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature. 400:1999;276-280.
24. Nakamura Y. Cleaning up on β-catenin. Nat. Med. 3:1997;499-500.
25. Baeg G.H., Matsumine A., Kuroda T., Bhattacharjee R.N., Miyashiro I., Toyoshima K., Akiyama T. The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. Eur. Mol. Biol. Org. J. 14:1995;5618-5625.
26. Heinen C.D., Goss K.H., Cornelius J.R., Babcock G.F., Knudsen E.S., Kowalik T., Groden J. The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway. Gastroenterology. 123:2002;751-763.
27. Mimori-Kiyosue Y., Tsukita S. Where is APC going? J. Cell Biol. 154:2001;1105-1109.
28. Fodde R., Kuipers J., Rosenberg C., Smits R., Kielman M., Gaspar C., et al. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell Biol. 3:2001;433-438.
29. Kaplan K.B., Burds A.A., Swedlow J.R., Bekir S.S., Sorger P.K., Nathke I.S. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat. Cell Biol. 3:2001;429-432.
30. Miyoshi Y., Nagase H., Ando H., Horii A., Ichii S., Nakatsuru S., et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1:1992;229-233.
31. Miyaki M., Konishi M., Kikuchi-Yanoshita R., Enomoto M., Igari T., Tanaka K., et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res. 54:1994;3011-3020.
32. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58:1998;1130-1134.
33. Oda H., Imai Y., Nakatsuru Y., Hata J., Ishikawa T. Somatic mutations of the APC gene in sporadic hepatoblastomas. Cancer Res. 56:1996;3320-3323.
34. Nakatsuru S., Yanagisawa A., Ichii S., Tahara E., Kato Y., Nakamura Y., Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum. Mol. Genet. 1:1992;559-563.
35. Clements W.M., Wang J., Sarnaik A., Kim O.J., MacDonald J., Fenoglio-Preiser C., et al. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62:2002;3503-3506.
36. Dimberg J., Hugander A., Sirsjo A., Soderkvist P. Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. Anticancer Res. 21:2001;911-915.
37. Virmani A.K., Rathi A., Sathyanarayana U.G., Padar A., Huang C.X., Cunnigham H.T., et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 7:2001;1998-2004.
38. Zochbauer-Muller S., Gazdar A.F., Minna J.D. Molecular pathogenesis of lung cancer. Annu. Rev. Physiol. 64:2002;681-708.
39. Usadel H., Brabender J., Danenberg K.D., Jeronimo C., Harden S., Engles J., et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res. 62:2002;371-375.